December 18 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Friday that its CEO Ognyan Donev acquired 41,631 shares in the company at a weighted average price of 3.18 levs ($1.99/1.63 euro) on December 17.